CorNeat EverPatch

DEVICE3 trials

Sponsors

CorNeat Vision Ltd., CorNeat Vision Ltd

Conditions

Eye Diseases SurgeryGlaucoma EyeTissue Breakdown

Unknown Phase

First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute

TerminatedNCT04037917

CorNeat Vision Ltd.Glaucoma Eye, Tissue Breakdown

Start: 2020-12-11End: 2023-07-01Updated: 2023-09-07

The CorNeat EverPatch is a First-In-Human clinical study aimed at demonstrating the safety of a synthetic tissue substitute for covering a glaucoma tube shunt.

Active, not recruitingPACTR202007844168087

CorNeat Vision LtdEye Diseases Surgery

Start: 2020-08-01Target: 15Updated: 2026-08-03

Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants

TerminatedNCT05469867

CorNeat Vision Ltd.Glaucoma Eye, Tissue Breakdown

Start: 2022-08-16End: 2024-06-18Updated: 2024-06-27